Waters Corporation (NYSE:WAT) today announced the acquisition of Rapid
Evaporative Ionization Mass Spectrometry (REIMS) technology from
MediMass Ltd. The REIMS technology represents substantially all of the
assets of MediMass and includes patent applications, software, databases
and REIMS expertise.
“While showing promise across many applications, REIMS technology
significantly strengthens Waters’ technology position within Health
Sciences,” said Rohit Khanna, Vice-President, Worldwide Marketing and
Informatics, Waters Division. “This technology acquisition along with
our recent agreement with Prosolia, Inc. for the exclusive rights to
Desorption Electrospray Ionization (DESI) technology in clinical
applications are key components in our burgeoning Heath Sciences
initiative. Both direct-from-sample ion source technologies are
strategic discriminators as we look to grow the impact of mass
spectrometry throughout the Health Sciences Continuum."
REIMS is the enabling technology for the "Intelligent Knife" or
“iKnife,” a device in the conceptual stages of development that could
potentially be used for real-time diagnostics in surgery. Waters is
committed to exploring the viability of this application in accordance
with all applicable regulatory requirements. To date, no regulatory
approvals have been sought for this device.
Waters' experience with REIMS technology stems from a three-year
collaboration among Waters, MediMass and Imperial College London focused
on advancing REIMS. The goal of this relationship has been and continues
to be advancing REIMS technology capabilities for health science
applications.
REIMS is an ionization technique that can be used as a source for direct
analysis of samples by mass spectrometry. To date, REIMS technology has
shown the ability to bring ambient ionization sampling into real world
applications such as food safety, microbiology and clinical diagnostic
applications.
The transient nature of the REIMS signals is ideally suited for Waters'
time-of-flight mass spectrometers. A REIMS ion source will be made
commercially available to complement the current range of ionization
sources on Waters Universal Ion Source platforms.
About Waters Corporation (www.waters.com)
For more than 50 years, Waters Corporation has created business
advantages for laboratory-dependent organizations by delivering
practical and sustainable innovation to enable significant advancements
in such areas as healthcare delivery, environmental management, food
safety, and water quality, consumer products and high-value added
chemicals worldwide.
Pioneering a connected portfolio of separations science, laboratory
information management, mass spectrometry and thermal analysis, Waters
technology breakthroughs and laboratory solutions provide an enduring
platform for customer success.
With revenue of $1.9 billion in 2013, Waters is driving scientific
discovery and operational excellence for customers worldwide.
Waters is a registered trademarks of Waters Corporation.
Copyright Business Wire 2014